AntiVEGF therapy | Private Healthcare UK
Advertisement

AntiVEGF therapy

AntiVEGF therapy

Anti-VEGF, 'vascular endothelial growth factor', medication is a treatment that can help stop the progression of wet AMD. This medication Lucentis (Ranibizumab) has to be injected into the eye using a very fine needle under local anaesthetic. This typically results in prevention of further loss of vision, and can also lead to improved vision. The patient will need to be monitored for further leakage of fluid in the eye.

Eylea (Aflibercept) is also an AntiVEGF therapy and works by targeting abnormal retinal blood vessels, reducing or stopping the bleeding and leakage . This typically results in prevention of further loss of vision, and can also lead to improved vision.

Costs and funding

Costs and funding

Lowest Average Highest
£558 £1,483 £6,900

Features

Latest news

Two out of five private hospitals in England do not meet safety standards intended to protect the...

Feedback from patients at BMI Three Shires Hospital in Cliftonville has shown that 99.2% of those...

Feedback from patients at BMI The Manor Hospital in Biddenham has shown that 99.0% of those who...

Find a ...

Advertisement
Advertisement
Connect with us on: